BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Med’s Industry

GE HealthCare Secures CE Mark for Carevance™ Patient Monitor, Advancing Accessible and Reliable Acute Care Across Europe

Built on GE HealthCare’s 50+ years of clinical excellence in patient monitoring, Carevance is an advanced, reliable monitoring solution that leve...

October 23, 2025 | News

Olympus Launches THUNDERBEAT™ II, a Next-Generation Hybrid Energy Device for Precision and Versatility in Surgery

THUNDERBEAT™ II features the versatility of three energy modes to support surgeons in adapting to challenging clinical conditions Olympus Corporatio...

October 22, 2025 | News

Sanofi’s Efluelda (Fluzone High-Dose) Cuts Influenza Hospitalisations by 31.9% in Adults Aged 65+

Compared to standard-dose influenza vaccines, Efluelda/Fluzone High-Dose demonstrated a reduction in laboratory-confirmed influenza hospitalizations by a...

October 21, 2025 | News

PeptiDream, PDRadiopharma, and Curium Launch Registrational Phase 2 Trial in Japan for 64Cu-PSMA-I&T Targeting Prostate Cancer

PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter "PeptiDream")(Tokyo: 4587), PDRadiopharm...

October 17, 2025 | News

NUH and NUS Launch Singapore’s First Total-Body PET/CT Centre in Partnership with Siemens Healthineers

Powered by Singapore's first next-generation total-body PET/CT system, the new facility aims to transform diagnostics, treatment and research i...

October 17, 2025 | News

Scanogen Secures FDA Breakthrough Device Designation for Rapid Sepsis Diagnostic in the United States

-Scanogen Inc., a molecular diagnostics company pioneering next-generation technologies for infectious disease detection, announced that the U.S. Food and ...

October 16, 2025 | Regulatory

Ascletis’ Denifanstat (ASC40) Achieves Phase III Success in Moderate-to-Severe Acne Vulgaris

Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulga...

October 15, 2025 | News

Asia University and NucleicAI Forge Alliance to Build Taiwan’s First Sovereign AI Life Science Data Platform

Asia University will partner with NucleicAI LLC, a next-generation platform and data company specializing in AI-driven genomics, precision m...

October 15, 2025 | News

Ascletis Selects ASC35 as Once-Monthly, Dual GLP-1/GIP Peptide Agonist Candidate for Obesity Treatment

- In head-to-head non-human primate (NHP) studies, average observed half-life of ASC35 was approximately 14 days, 6-fold longer than tirzepatide, whic...

October 14, 2025 | News

Lundbeck’s Bexicaserin Receives Breakthrough Therapy Designation in China for Severe Childhood Epilepsies

Accelerated pathway underscores urgent need for innovative solutions for patients with devastating, childhood-onset epilepsies Novel 5HT2C mechanism des...

October 14, 2025 | News

Berlin Heals Completes Enrollment in First-in-Human Study of Less Invasive Heart Failure Therapy

Completed Enrollment in First-In-Human Phase I study of Less Invasive Approach Expected to Present 6-Month data in 2026 at a major Cardiology Congress ...

October 13, 2025 | News

Roche and OASES Partner to Advance Healthcare Innovation in Hong Kong

Roche announced its strategic collaboration with the Office for Attracting Strategic Enterprises (OASES) to accelerate healthcare innovation and stre...

October 13, 2025 | News

Sandstone Medical Expands Easydrip™ Plus Pen Needle Portfolio to Turkey

Sandstone Medical — a SteriLance Medical sub‑brand focused on diabetes self‑injection — announced the introduction of its Easydr...

October 13, 2025 | News

Gunze Medical Secures Exclusive Japan Distribution Rights for HistoSonics’ Noninvasive Histotripsy Therapy

Gunze Limited (Headquarters: Osaka, Japan; President: Toshiyasu Saguchi) [TOKYO:3002] is pleased to announce that its wholly owned subsidiary, Gunze Medica...

October 10, 2025 | News

Stay Connected